BHLHE40 and malignant colon neoplasm: Given that BHLHE40 expression affects the T cell repertoire and thus likely modulates inflammatory responses in colorectal cancer (28), it is possible that BHLHE40 ablation in the immune cells rather than the colon epithelium antagonized azoxymethane/dextran sulfate-induced cell transformation and thereby colon cancer development.